<?xml version="1.0" encoding="UTF-8"?>
<p>Hepatitis C virus (HCV) infection is still a serious health problem worldwide, especially in the human immunodeficiency virus (HIV)-infected population. The mono-HCV infection has been a handicap for the healthcare system, and about 71 millions of HCV-infected persons developed chronic infection. Approximately 399 thousands of people died because of hepatitis C or diseases caused by HCV infection (cirrhosis and hepatocellular carcinoma (HCC)) each year [
 <xref rid="ref1" ref-type="bibr">1</xref>]. HCV infection in the HIV-infected population is more prevalent than the general population, but the occurring rate varied [
 <xref rid="ref2" ref-type="bibr">2</xref>]. Until 2017, a total of 36.7 million persons have been infected with HIV worldwide, and about 1 million infected individuals died [
 <xref rid="ref3" ref-type="bibr">3</xref>]. Currently, there is no vaccine to prevent persons from HCV and/or HIV infection, so HCV and HIV co-infection needs more attention.
</p>
